GHDX: Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX(R) as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients

New alert via PocketInfo for GHDX:

Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX(R) as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients

Press Releases: http://investor.genomichealth.com/releases.cfm
SEC Filings: http://investor.genomichealth.com/sec.cfm
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8